ENANTA PHARMACEUTICALS, INC Class of Warrant or Right, Outstanding
ENANTA PHARMACEUTICALS, INC (ENTA) had Class of Warrant or Right, Outstanding of 0 shares as of 2018-09-30, per its 10-K filed 2018-11-29.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2018-11-29
- 2018-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-03-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2017-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2018-09-30 | 0.00 shares 10-K · filed 2018-11-29 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |